Luminal-like breast cancer, which includes luminal A and B subtypes, is characterized by the expression of estrogen receptor (ER) and/or progesterone (PR) and confers a more favorable prognosis partially due to anti-hormone therapy responsiveness4. The gene discussed is ESR1; the disease is breast carcinoma.